Sun-Ranbaxy merger may spill over to 2015

The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region Sun......

Sun Pharma seeks shareholders' nod for Rs 12,000-crore QIP

Sun Pharmaceutical Industries, India's largest drug maker by value, is looking to get shareholders' approval to raise qualified institutional placement worth Rs 12,000 crore (Rs 120 billion) at its......

Sun Pharma unit recalls mutiple lots of capsules from US

Caraco Pharmaceutical Laboratories , a unit of Sun Pharma, has initiated a recall of multiple lots of Cephalexin capsules from the US market. According to a notification by the USFDA, the recall of......

Indian firms eye $2.5-bn US drug market

Indian pharmaceutical majors are set to tap the generic anti-depressant market in the US, the largest pharma market in the world. The anti-depressant drug market in the US is primarily ruled by......